CD274 and non-small cell lung carcinoma: Moreover, the efficacy of immunotherapy in combination with platinum-based chemotherapy versus chemotherapy alone was demonstrated in two phase III randomized trials in patients with metastatic NSCLC, regardless of PD-L1 expression levels [4,5].